Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?

Abstract

We bring to you our viewpoint and a snapshot of the journey of convalescent plasma therapy (CPT) in the management of ongoing coronavirus disease 2019 (COVID-19) pandemic. We also discuss how best to use the updated data on this important treatment option and maximize benefit for our patients, thereby saving lives, especially in resource constraint settings.

Keywords

• pandemic
• sars-cov-2
• antibodies
• immunity
• titer
• donor